Price movement over the last 24 hours
Arita Prima Indonesia Tbk vs Medco Energi Internasional Tbk. — how do they compare? Arita Prima Indonesia Tbk trades at Rp182 (market cap 200.09B, 17.2K 24h volume), while Medco Energi Internasional Tbk. trades at Rp1,170 (market cap 28.28T, 72.9M 24h volume). The key difference: Medco Energi Internasional Tbk. is far larger — about 141.3× Arita Prima Indonesia Tbk's market cap, and Medco Energi Internasional Tbk. is more actively traded (72.9M versus 17.2K). Which is the better fit depends on your goals.
| APII | MEDC | |
|---|---|---|
Market Cap | 200.09B | 28.28T |
Volume | 17.2K | 72.9M |
Lot | 172 | 728.97K |
Turnover | 3.14M | 84.45B |
Average Price | 182.51 | 1,158.48 |
Value | 3.14M | 84.45B |
Indicative Equilibrium Price | — | 1,170 |
Indicative Equilibrium Volume | — | 111.42K |
Trailing returns across standard periods
Latest headlines on both assets
PT Arita Prima Indonesia Tbk (the Company) was established on October 5, 2000. Since its founding in 2000, the company initially marketed under the brand Arita valve products manufactured by Unimech Group, a multinational business group from Malaysia that specializes in construction services and valve manufacturers, as well as supporting products. The Company is the only company that was granted by the relevant manufacturers in the distribution and marketing in Indonesia, for valve products from leading manufacturers in the world with brands Arita from Malaysia, RK Marine from China, and KVC from Japan.
Read more on APII →PT Medco Energi Internasional Tbk (the Company) was established within the framework of the Domestic Capital Investment Law No. 6 year 1968 as amended by Law No. 12 year 1970, based on notarial deed No. 19 of Imas Fatimah, S.H., dated June 9, 1980. Medco Energi Corporation is holding company for energy related business within the Medco Group of companies. On March 1997 the company cooperated with Myanmar Oil and Gas Enterprise plan to handle 8,000 m2 of suspended field in Myanmar. Company is a PMDN
Read more on MEDC →